Suraamornkul S - Search Results

1

Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study).

Cho YM, Deerochanawong C, Seekaew S, Suraamornkul S, Benjachareonwong S, Sattanon S, Chamnan P, Sirirak T, Kosachunhanun N, Pratipanawatr T, Suwanwalaikorn S, Lee WJ, Kim S, Choi S, Kang ES, Oh T, Kwon S, Lee MK. Cho YM, et al. Among authors: suraamornkul s. Diabetes Obes Metab. 2020 Jan;22(1):123-127. doi: 10.1111/dom.13873. Epub 2019 Oct 8. Diabetes Obes Metab. 2020. PMID: 31478335 Clinical Trial.

2

Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.

Bajaj M, Suraamornkul S, Pratipanawatr T, Hardies LJ, Pratipanawatr W, Glass L, Cersosimo E, Miyazaki Y, DeFronzo RA. Bajaj M, et al. Among authors: suraamornkul s. Diabetes. 2003 Jun;52(6):1364-70. doi: 10.2337/diabetes.52.6.1364. Diabetes. 2003. PMID: 12765945

3

A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.

Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, Stein H; Gluco VIP study. Zhang W, et al. Clin Drug Investig. 2013 Apr;33(4):263-74. doi: 10.1007/s40261-013-0063-3. Clin Drug Investig. 2013. PMID: 23435929

4

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA. Bajaj M, et al. Among authors: suraamornkul s. J Clin Endocrinol Metab. 2004 Jan;89(1):200-6. doi: 10.1210/jc.2003-031315. J Clin Endocrinol Metab. 2004. PMID: 14715850

5

Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial.

Trakarnvanich T, Satirapoj B, Suraamornkul S, Chirananthavat T, Sanpatchayapong A, Claimon T. Trakarnvanich T, et al. Among authors: suraamornkul s. J Diabetes Res. 2021 Oct 16;2021:7382620. doi: 10.1155/2021/7382620. eCollection 2021. J Diabetes Res. 2021. PMID: 34697593 Free PMC article. Clinical Trial.

6

Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients.

Bajaj M, Suraamornkul S, Hardies LJ, Pratipanawatr T, DeFronzo RA. Bajaj M, et al. Among authors: suraamornkul s. Int J Obes Relat Metab Disord. 2004 Jun;28(6):783-9. doi: 10.1038/sj.ijo.0802625. Int J Obes Relat Metab Disord. 2004. PMID: 15024400

7

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F; EXAMINE Investigators. White WB, et al. N Engl J Med. 2013 Oct 3;369(14):1327-35. doi: 10.1056/NEJMoa1305889. Epub 2013 Sep 2. N Engl J Med. 2013. PMID: 23992602 Free article. Clinical Trial.

8

A Consensus of Key Opinion Leaders on the Management of Pre-diabetes in the Asia-Pacific Region.

Mirasol R, Thai AC, Salahuddin AA, Tan K, Deerochanawong C, Mohamed M, Saraswati MR, Sethi BK, Shah S, Soetedjo NN, Suraamornkul S, Tan R, Uddin F. Mirasol R, et al. Among authors: suraamornkul s. J ASEAN Fed Endocr Soc. 2017;32(1):6-12. doi: 10.15605/jafes.032.01.02. Epub 2017 May 5. J ASEAN Fed Endocr Soc. 2017. PMID: 33442078 Free PMC article.

9

Efficacy and safety of ivermectin in the treatment of mild to moderate COVID-19 infection: a randomized, double-blind, placebo-controlled trial.

Manomaipiboon A, Pholtawornkulchai K, Poopipatpab S, Suraamornkul S, Maneerit J, Ruksakul W, Phumisantiphong U, Trakarnvanich T. Manomaipiboon A, et al. Among authors: suraamornkul s. Trials. 2022 Aug 26;23(1):714. doi: 10.1186/s13063-022-06649-3. Trials. 2022. PMID: 36028897 Free PMC article. Clinical Trial.

10

Insulin clamp-derived measurements of insulin sensitivity and insulin secretion in lean and obese asian type 2 diabetic patients.

Suraamornkul S, Kwancharoen R, Ovartlarnporn M, Rawdaree P, Bajaj M. Suraamornkul S, et al. Metab Syndr Relat Disord. 2010 Apr;8(2):113-8. doi: 10.1089/met.2009.0030. Metab Syndr Relat Disord. 2010. PMID: 20059360 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page